26 related articles for article (PubMed ID: 31309997)
21. [Frequent involvement of the amyloid pathway in prodromal dementia with Lewy bodies].
Monge-Argiles JA; Monge-Garcia V; Gasparini-Berenguer R; Garcia-Perez C; Gabaldon-Torres L; Salas-Felipe J; Leiva-Santana C
Rev Neurol; 2019 Aug; 69(3):89-93. PubMed ID: 31309997
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid in the dementias.
Zetterberg H; Rohrer JD; Schott JM
Handb Clin Neurol; 2017; 146():85-97. PubMed ID: 29110781
[TBL] [Abstract][Full Text] [Related]
23. [Biomarkers in spinal fluid of patients with dementia].
Skogseth RE; Fladby T; Mulugeta E; Aarsland D
Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2235-8. PubMed ID: 22085948
[TBL] [Abstract][Full Text] [Related]
24. Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein.
Hampel H; Goernitz A; Buerger K
Brain Res Bull; 2003 Aug; 61(3):243-53. PubMed ID: 12909294
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of Alzheimer's biomarkers in cerebrospinal fluid in dementia with Lewy body.
Bousiges O; Blanc F
Geriatr Psychol Neuropsychiatr Vieil; 2018 Jun; 16(2):174-180. PubMed ID: 29877185
[TBL] [Abstract][Full Text] [Related]
26. Lewy Body Dementias: Controversies and Drug Development.
Chiu SY; Bowers D; Armstrong MJ
Neurotherapeutics; 2022 Jan; 19(1):55-67. PubMed ID: 34859379
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
